Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone hyperresorption in multiple myeloma].

J Beaudreuil1, P Orcel

  • 1Centre Viggo Petersen, Hôpital Lariboisière Paris. fed.rhumatol@lrb.ap-hop-paris.fr

Presse Medicale (Paris, France : 1983)
|April 4, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiation-induced undifferentiated pleomorphic sarcoma after radiation therapy for a desmoid tumour.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2016
Same author

Hospitalization for Dupuytren's disease: a French national descriptive analysis, 2002 to 2009.

Orthopaedics & traumatology, surgery & research : OTSR·2014
Same author

Re: Rodrigues JN, Zhang W, Scammell BE, Davis TRC. What patients want from the treatment of Dupuytren's disease - is the Unité Rhumatologique des Affections de la Main (URAM) scale relevant? J Hand Surg Eur. Epub ahead of print 21 February 2014. DOI: 10.1177/1753193414524689.

The Journal of hand surgery, European volume·2014
Same author

Diagnostic value of clinical tests for degenerative rotator cuff disease in medical practice.

Annals of physical and rehabilitation medicine·2014
Same author

Validation of a French version of Roland-Morris questionnaire in chronic low back pain patients.

Annals of physical and rehabilitation medicine·2013
Same author

Poliomyelitis sequels in France and the clinical and social needs of survivors: a retrospective study of 200 patients.

Annals of physical and rehabilitation medicine·2013
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Multiple myeloma causes bone destruction, leading to osteolysis and hypercalcemia. Bisphosphonates effectively treat these bone complications and slow disease progression in patients.

Area of Science:

  • Oncology
  • Hematology
  • Bone Biology

Background:

  • Multiple myeloma is a high-grade lymphoproliferative syndrome with a predilection for bone involvement.
  • Bone-related complications, including osteolysis and hypercalcemia, affect a significant proportion of multiple myeloma patients (80% and 30%, respectively).
  • These complications stem from excessive bone resorption driven by osteoclast activity, outpacing bone formation.

Purpose of the Study:

  • To elucidate the mechanisms underlying osteolysis and hypercalcemia in multiple myeloma.
  • To highlight the role of bisphosphonates in managing bone manifestations of multiple myeloma.

Main Methods:

  • Histomorphometric studies and biochemical markers of bone resorption were used to assess bone destruction.
  • The study examined the complex interactions between tumor plasma cells, bone cells, and stem cells, involving local factors and adhesion molecules.

Related Experiment Videos

Main Results:

  • Bone destruction in multiple myeloma is a significant and measurable process.
  • Excessive bone resorption is driven by intricate cellular and molecular interactions.
  • Bisphosphonates demonstrate efficacy in treating hypercalcemia and inhibiting bone disease progression.

Conclusions:

  • Bisphosphonates represent a major therapeutic advancement for bone-related issues in multiple myeloma.
  • These agents not only manage hypercalcemia but also contribute to controlling the skeletal disease progression.